Orion Pharma Limited reported consolidated unaudited earnings results for the first quarter ended September 30, 2016. For the period, the company reported consolidated EPS of BDT 1.17 against BDT 0.73 a year ago. Consolidated NOCFPS was BDT 1.33 against BDT 1.08 a year ago. Consolidated NAV per share was BDT 71.09 as of September 30, 2016 and BDT 69.48 as of September 30, 2015.